drugset / Trial / NCT06843460
A Clinical Study of MK-7962 in Healthy Chinese Participants (MK-7962-021)
RandomizedSequentialDouble-blindTreatment
Summary
The goal of this study is to learn about the safety of 2 different amounts of sotatercept and if healthy Chinese people tolerate them. The study will also measure what happens to sotatercept in a person's body over time (pharmacokinetic or PK study).
Timeline
- Start
- 2023-11-22
- Primary completion
- 2024-05-21
- Completion
- 2024-05-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sotatercept | Protein / enzyme biologic | 0.3 mg/kg | Subcutaneous |
| Subject | Sotatercept | Protein / enzyme biologic | 0.7 mg/kg | Subcutaneous |
Indications
No indication recorded.